3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
24
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Waldenstrom Macroglobulinemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Immunoglobulin Light-chain Amyloidosis
1
Burkitt Lymphoma
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Cyclophosphamide
4
fludarabine phosphate
3
Epoetin Alfa
3
Darbepoetin alfa
3
Whole-Body Irradiation
2
Tacrolimus
2
Mycophenolic Acid
2
Morphine
2
Methylprednisolone
2
Interferon-alpha
2
Filgrastim
2
Cyclosporine
2
Carboplatin
2
Busulfan
2
Antilymphocyte Serum
2
sargramostim
1
pyroxamide
1
ferrous sulfate
1
ferric gluconate
1
aldesleukin
1
Topotecan
1
Therapeutics
1
Tetradecanoylphorbol Acetate
1
Sucrose
1
Radiotherapy
1
Prednisone
1
Phenytoin
1
Pemetrexed
1
Oxycodone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
Bortezomib
×
Other neoplasm
×
Clear all
NCT00006362
2011-08-03
PS-341 in Treating Patients With Advanced Cancer
Mayo Clinic
Phase 1
Completed